Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Rummel, Mathias, Prof, Kaiser, Ulrich, Prof, Balser, Christina, MD, Stauch, Martina, MD, Brugger, Wolfram, Prof, Welslau, Manfred, MD, Niederle, Norbert, Prof, Losem, Christoph, MD, Boeck, Hans-Peter, MD, Weidmann, Eckhart, Prof, von Gruenhagen, Ulrich, MD, Mueller, Lothar, MD, Sandherr, Michael, MD, Hahn, Lars, MD, Vereshchagina, Julia, MD, Kauff, Frank, PhD, Blau, Wolfgang, MD, Hinke, Axel, PhD, Barth, Juergen, Pharmacist
Published in The lancet oncology (01.01.2016)
Published in The lancet oncology (01.01.2016)
Get full text
Journal Article